CAPITOL COUNSEL LLC for MERCK & COMPANY, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 22, 2018 | $30,000 | Replaced |
| 4th Quarter - Amendment | Apr 30, 2020 | $30,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Legislative issues related to tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANNON FINLEY | — |
| JAMES O MCCRERY | — |
| DAVID OLANDER | — |
Copyright/Patent/Trademark CPT
Legislative issues related to Pharmaceutical patent issues; Legislative issues related to the FDA Regulation of Biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARON COHEN | — |
| SHANNON FINLEY | — |
| CHARLES TOWNER FRENCH | — |
| DREW GOESL | — |
| MARTIN B. GOLD | — |
| LUKE HATZIS | — |
| JAMES O MCCRERY | — |
| DAVID OLANDER | — |
| JOHN D RAFFAELLI | — |
Medicare/Medicaid MMM
Medicare Coverage and Reimbursement issues, including the CMS Part B Drug Demonstration Proposed Rule; Medicare reimbursement for antimicrobial drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARON COHEN | — |
| SHANNON FINLEY | — |
| SARA FRANKO | — |
| CHARLES TOWNER FRENCH | — |
| DREW GOESL | — |
| MARTIN B. GOLD | — |
| LUKE HATZIS | — |
| ANN JABLON | — |
| JOHN D RAFFAELLI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.